Contact
searchSearch
HMP Global

The Dermatologist

Featured

Quiz
Type 2 Endotypes and Therapeutic Strategy in Prurigo Nodularis
06/25/2026
Riya Gandhi, MA
Assess advanced concepts in type 2 inflammatory endotypes, shared therapeutic pathways, and practical treatment approaches in prurigo nodularis.
Assess advanced concepts in type 2 inflammatory endotypes, shared therapeutic pathways, and practical treatment approaches in prurigo nodularis.
Assess advanced concepts in type...
06/25/2026
The Dermatologist
Part 5 panel
Videos
Safety Monitoring in High-Risk CSCC
06/24/2026
Christopher Barker, MD; Krupal Patel, MD, MSc, FRCSC, FACS; John Strasswimmer, MD, PhD, FAAD, FACMS; Deborah J.L. Wong, MD, PhD
The roundtable discussion concludes with a review of the safety profile of adjuvant cemiplimab and best practices for monitoring and managing adverse events in patients with high-risk CSCC, with an emphasis on multidisciplinary follow-up,...
The roundtable discussion concludes with a review of the safety profile of adjuvant cemiplimab and best practices for monitoring and managing adverse events in patients with high-risk CSCC, with an emphasis on multidisciplinary follow-up,...
The roundtable discussion...
06/24/2026
The Dermatologist
Video 2 Drs Strasswimmer and Wong
Videos
Applying High-Risk Criteria in CSCC Practice
06/24/2026
Christopher Barker, MD; Krupal Patel, MD, MSc, FRCSC, FACS; John Strasswimmer, MD, PhD, FAAD, FACMS; Deborah J.L. Wong, MD, PhD
The case-based discussion continues with an exploration of how high-risk features inform treatment decisions in clinical practice. The multidisciplinary panel discusses real-world application of C-POST eligibility criteria and the importance...
The case-based discussion continues with an exploration of how high-risk features inform treatment decisions in clinical practice. The multidisciplinary panel discusses real-world application of C-POST eligibility criteria and the importance...
The case-based discussion...
06/24/2026
The Dermatologist
Part 3 panel
Videos
Multidisciplinary Coordination in High-Risk CSCC
06/24/2026
Christopher Barker, MD; Krupal Patel, MD, MSc, FRCSC, FACS; John Strasswimmer, MD, PhD, FAAD, FACMS; Deborah J.L. Wong, MD, PhD
In this video, the panel highlights the importance of early multidisciplinary collaboration in the management of high-risk CSCC. The experts discuss evolving referral patterns, the role of the tumor board, and the importance of coordinated...
In this video, the panel highlights the importance of early multidisciplinary collaboration in the management of high-risk CSCC. The experts discuss evolving referral patterns, the role of the tumor board, and the importance of coordinated...
In this video, the panel...
06/24/2026
The Dermatologist
Part 2 Patel and Barker
Videos
Integrating Adjuvant Therapy in High-Risk CSCC
06/24/2026
Christopher Barker, MD; Krupal Patel, MD, MSc, FRCSC, FACS; John Strasswimmer, MD, PhD, FAAD, FACMS; Deborah J.L. Wong, MD, PhD
The discussion turns to the role of adjuvant therapy for patients with high-risk CSCC, highlighting key findings from the C-POST trial. Through case-based discussion, the panel explores patient selection, treatment sequencing, and practical...
The discussion turns to the role of adjuvant therapy for patients with high-risk CSCC, highlighting key findings from the C-POST trial. Through case-based discussion, the panel explores patient selection, treatment sequencing, and practical...
The discussion turns to the role...
06/24/2026
The Dermatologist
Drs Patel, Barker, Strasswimmer, and Wong
Videos
Recognizing High-Risk CSCC
06/24/2026
Christopher Barker, MD; Krupal Patel, MD, MSc, FRCSC, FACS; John Strasswimmer, MD, PhD, FAAD, FACMS; Deborah J.L. Wong, MD, PhD
In this video, the multidisciplinary panel reviews the clinical, pathologic, and patient-related features that define high-risk CSCC, including tumor characteristics, nodal involvement, perineural invasion, and immunocompromised status. The...
In this video, the multidisciplinary panel reviews the clinical, pathologic, and patient-related features that define high-risk CSCC, including tumor characteristics, nodal involvement, perineural invasion, and immunocompromised status. The...
In this video, the...
06/24/2026
The Dermatologist
itch
Quiz
Fibrosis and Persistent Itch in Prurigo Nodularis
06/15/2026
Riya Gandhi, MA
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your clinical understanding...
06/15/2026
The Dermatologist
sunscreen
News
FDA Approves Bemotrizinol: What Dermatologists Need to Know
06/11/2026
Jane Y. Yoo, MD; Riya Gandhi, MA
The Dermatologist spoke with Dr Jane Yoo about the FDA’s landmark approval of bemotrizinol. Dr Yoo discusses how this photostable, broad-spectrum UV filter may improve UVA protection, expand cosmetically elegant sunscreen options for diverse...
The Dermatologist spoke with Dr Jane Yoo about the FDA’s landmark approval of bemotrizinol. Dr Yoo discusses how this photostable, broad-spectrum UV filter may improve UVA protection, expand cosmetically elegant sunscreen options for diverse...
The Dermatologist spoke with Dr...
06/11/2026
The Dermatologist
Elliott Campbell
Videos
Innovations in Systemic Therapy for Advanced Nonmelanoma Skin Cancers
06/10/2026
Elliott Campbell, MD, FAAD; Riya Gandhi, MA
Explore the evolving treatment landscape for advanced basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (CSCC).
Explore the evolving treatment landscape for advanced basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (CSCC).
Explore the evolving treatment...
06/10/2026
The Dermatologist
FDA Alert
FDA Alerts
FDA Approves Every-8-Week Maintenance Dosing Option for Lebrikizumab in Atopic Dermatitis
06/10/2026
Jessica Garlewicz
The FDA approved an every-8-week maintenance dosing regimen for Ebglyss (lebrikizumab-lbkz), providing a new administration option for adults and adolescents aged 12 years and older weighing at least 40 kg with moderate-to-severe atopic...
The FDA approved an every-8-week maintenance dosing regimen for Ebglyss (lebrikizumab-lbkz), providing a new administration option for adults and adolescents aged 12 years and older weighing at least 40 kg with moderate-to-severe atopic...
The FDA approved an every-8-week...
06/10/2026
The Dermatologist
nail
News
Nail Abnormalities Common in Severe Atopic Dermatitis, Study Finds
06/09/2026
Jessica Garlewicz
Nail abnormalities may be highly prevalent among adults with severe atopic dermatitis (AD) and appear closely associated with disease severity.
Nail abnormalities may be highly prevalent among adults with severe atopic dermatitis (AD) and appear closely associated with disease severity.
Nail abnormalities may be highly...
06/09/2026
The Dermatologist

From The Issue

Derm Dx
What Caused This Recurrent Eruption on the Neck, Ears, and Shoulders?
06/08/2026
Lanah Almatroud, BA; Amor Khachemoune, MD, FAAD, FACMS
A 29-year-old woman presented for a dermatologic evaluation with erythematous pustular lesions involving the face, ear, neck, shoulder, and scapular areas.
A 29-year-old woman presented for a dermatologic evaluation with erythematous pustular lesions involving the face, ear, neck, shoulder, and scapular areas.
A 29-year-old woman presented...
06/08/2026
The Dermatologist
Clinical Tips
Standardize Before-and-After Photography
06/08/2026
Benjamin Barankin, MD, FRCPC
Keep these tips in mind for your next appointment!
Keep these tips in mind for your next appointment!
Keep these tips in mind for your...
06/08/2026
The Dermatologist
Cover Story
To Screen or Not to Screen? Rethinking Biologic Monitoring in the Modern Era
06/08/2026
Scott Andrew Elman, MD, FAAD
Dermatologists who build vaccination review, mechanism-specific monitoring, and shared decisionmaking into their standard biologic workflow will be better positioned to give their patients safer and more efficient care.
Dermatologists who build vaccination review, mechanism-specific monitoring, and shared decisionmaking into their standard biologic workflow will be better positioned to give their patients safer and more efficient care.
Dermatologists who build...
06/08/2026
The Dermatologist
Derm Dx
What Caused This Truncal Rash?
04/07/2026
George G. Papadeas, BS; Nicolia S. Christy, PA-C; Aamir N. Hussain, MD, MAPP
A 16-year-old African American adolescent boy with no known past medical history presented with a dark eruption involving the chest and abdomen ongoing for 1 year.
A 16-year-old African American adolescent boy with no known past medical history presented with a dark eruption involving the chest and abdomen ongoing for 1 year.
A 16-year-old African American...
04/07/2026
The Dermatologist
Cover Story
Evolution of Aesthetics in Dermatology
04/06/2026
Michael H. Gold, MD, FAAD; Brian S. Biesman, MD, FACS; Riya Gandhi, MA
As aesthetic and medical dermatology continue to converge, the therapeutic toolbox has never been more expansive. Join Drs Gold and Biesman in uncovering the latest developments.
As aesthetic and medical dermatology continue to converge, the therapeutic toolbox has never been more expansive. Join Drs Gold and Biesman in uncovering the latest developments.
As aesthetic and medical...
04/06/2026
The Dermatologist
Clinical Tips
Improving New Treatment Adherence
04/06/2026
Benjamin Barankin, MD, FRCPC
Keep these tips in mind for your next appointment!
Keep these tips in mind for your next appointment!
Keep these tips in mind for your...
04/06/2026
The Dermatologist
Cover Story
More Than Cosmetic: Reframing Hyperpigmentation as a Clinical and Psychosocial Priority
03/09/2026
Oyetewa Boluwatito Asempa, MD, FAAD; Coleen Stern, MA; Riya Gandhi, MA
Dr Oyetewa Asempa explores the clinical, psychosocial, and equity-driven imperatives reshaping how dermatologists diagnose and treat hyperpigmentation disorders in patients with skin of color.
Dr Oyetewa Asempa explores the clinical, psychosocial, and equity-driven imperatives reshaping how dermatologists diagnose and treat hyperpigmentation disorders in patients with skin of color.
Dr Oyetewa Asempa explores the...
03/09/2026
The Dermatologist
Feature Story
Biosimilars in Dermatology: What Clinicians Need to Know in 2026
03/09/2026
Omar Raheel, BA; Jade Bajic, BSc; Ryan Hirsh, BS; Steven R. Feldman, MD, PhD
Get the answers to key questions about biosimilars, including what they are, how they are regulated, and how they affect prescribing, insurance coverage, and patient care.
Get the answers to key questions about biosimilars, including what they are, how they are regulated, and how they affect prescribing, insurance coverage, and patient care.
Get the answers to key questions...
03/09/2026
The Dermatologist
Feature Story
Beyond the Gut: Recognizing and Managing Inflammatory Bowel Disease in Dermatologic Practice
03/09/2026
David Fudman, MD; Riya Gandhi, MA
Gastroenterologist Dr David Fudman examines our evolving understanding of the gut-skin axis and the pivotal role dermatologists play in identifying and comanaging the cutaneous symptoms of luminal disease.
Gastroenterologist Dr David Fudman examines our evolving understanding of the gut-skin axis and the pivotal role dermatologists play in identifying and comanaging the cutaneous symptoms of luminal disease.
Gastroenterologist Dr David...
03/09/2026
The Dermatologist
Derm Dx
What Is This Persistent Scaly Plaque in the Axilla?
03/09/2026
Aamir N. Hussain, MD, MAPP; Umayr R. Shaikh, MPH; Kabir Al-Tariq, MS; David Terrano, MD, PhD
A 55-year-old woman with a history of hypertension and nonalcoholic fatty liver disease presented with a pruritic rash localized to her right axilla for 2 months.
A 55-year-old woman with a history of hypertension and nonalcoholic fatty liver disease presented with a pruritic rash localized to her right axilla for 2 months.
A 55-year-old woman with a...
03/09/2026
The Dermatologist

Multimedia

Part 5 panel
Videos
Safety Monitoring in High-Risk CSCC
06/24/2026
Christopher Barker, MD; Krupal Patel, MD, MSc, FRCSC, FACS; John Strasswimmer, MD, PhD, FAAD, FACMS; Deborah J.L. Wong, MD, PhD
The roundtable discussion concludes with a review of the safety profile of adjuvant cemiplimab and best practices for monitoring and managing adverse events in patients with high-risk CSCC, with an emphasis on multidisciplinary follow-up,...
The roundtable discussion concludes with a review of the safety profile of adjuvant cemiplimab and best practices for monitoring and managing adverse events in patients with high-risk CSCC, with an emphasis on multidisciplinary follow-up,...
The roundtable discussion...
06/24/2026
The Dermatologist
Video 2 Drs Strasswimmer and Wong
Videos
Applying High-Risk Criteria in CSCC Practice
06/24/2026
Christopher Barker, MD; Krupal Patel, MD, MSc, FRCSC, FACS; John Strasswimmer, MD, PhD, FAAD, FACMS; Deborah J.L. Wong, MD, PhD
The case-based discussion continues with an exploration of how high-risk features inform treatment decisions in clinical practice. The multidisciplinary panel discusses real-world application of C-POST eligibility criteria and the importance...
The case-based discussion continues with an exploration of how high-risk features inform treatment decisions in clinical practice. The multidisciplinary panel discusses real-world application of C-POST eligibility criteria and the importance...
The case-based discussion...
06/24/2026
The Dermatologist
Part 3 panel
Videos
Multidisciplinary Coordination in High-Risk CSCC
06/24/2026
Christopher Barker, MD; Krupal Patel, MD, MSc, FRCSC, FACS; John Strasswimmer, MD, PhD, FAAD, FACMS; Deborah J.L. Wong, MD, PhD
In this video, the panel highlights the importance of early multidisciplinary collaboration in the management of high-risk CSCC. The experts discuss evolving referral patterns, the role of the tumor board, and the importance of coordinated...
In this video, the panel highlights the importance of early multidisciplinary collaboration in the management of high-risk CSCC. The experts discuss evolving referral patterns, the role of the tumor board, and the importance of coordinated...
In this video, the panel...
06/24/2026
The Dermatologist
Part 2 Patel and Barker
Videos
Integrating Adjuvant Therapy in High-Risk CSCC
06/24/2026
Christopher Barker, MD; Krupal Patel, MD, MSc, FRCSC, FACS; John Strasswimmer, MD, PhD, FAAD, FACMS; Deborah J.L. Wong, MD, PhD
The discussion turns to the role of adjuvant therapy for patients with high-risk CSCC, highlighting key findings from the C-POST trial. Through case-based discussion, the panel explores patient selection, treatment sequencing, and practical...
The discussion turns to the role of adjuvant therapy for patients with high-risk CSCC, highlighting key findings from the C-POST trial. Through case-based discussion, the panel explores patient selection, treatment sequencing, and practical...
The discussion turns to the role...
06/24/2026
The Dermatologist
Drs Patel, Barker, Strasswimmer, and Wong
Videos
Recognizing High-Risk CSCC
06/24/2026
Christopher Barker, MD; Krupal Patel, MD, MSc, FRCSC, FACS; John Strasswimmer, MD, PhD, FAAD, FACMS; Deborah J.L. Wong, MD, PhD
In this video, the multidisciplinary panel reviews the clinical, pathologic, and patient-related features that define high-risk CSCC, including tumor characteristics, nodal involvement, perineural invasion, and immunocompromised status. The...
In this video, the multidisciplinary panel reviews the clinical, pathologic, and patient-related features that define high-risk CSCC, including tumor characteristics, nodal involvement, perineural invasion, and immunocompromised status. The...
In this video, the...
06/24/2026
The Dermatologist
Elliott Campbell
Videos
Innovations in Systemic Therapy for Advanced Nonmelanoma Skin Cancers
06/10/2026
Elliott Campbell, MD, FAAD; Riya Gandhi, MA
Explore the evolving treatment landscape for advanced basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (CSCC).
Explore the evolving treatment landscape for advanced basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (CSCC).
Explore the evolving treatment...
06/10/2026
The Dermatologist
green
Videos
Hormonal Therapy in Acne: DHT, Spironolactone, and Clascoterone
06/04/2026
Lawrence J. Green, MD, FAAD; Riya Gandhi, MA
Dr Lawrence Green discusses how androgens and DHT contribute to acne pathogenesis through sebum production, inflammation, and abnormal keratinization.
Dr Lawrence Green discusses how androgens and DHT contribute to acne pathogenesis through sebum production, inflammation, and abnormal keratinization.
Dr Lawrence Green discusses how...
06/04/2026
The Dermatologist
Minokadeh
Videos
Injectables for the Male Face: Neuromodulator Dosing and Filler Techniques
06/04/2026
Ardalan Minokadeh, MD, PhD; Riya Gandhi, MA
Dr Ardalan Minokadeh discusses how injectable treatments should be tailored to male facial anatomy, including differences in muscle mass, brow shape, jaw structure, and midface contours.
Dr Ardalan Minokadeh discusses how injectable treatments should be tailored to male facial anatomy, including differences in muscle mass, brow shape, jaw structure, and midface contours.
Dr Ardalan Minokadeh discusses...
06/04/2026
The Dermatologist
Ablon
Videos
Dermatology Retail and Skincare Recommendations: Evidence-Based Strategies for Practices
06/04/2026
Glynis Ablon; Riya Gandhi, MA
Dr Glynis Ablon discusses how dermatology practices can build a clinically driven skincare retail strategy grounded in evidence-based care rather than marketing trends.
Dr Glynis Ablon discusses how dermatology practices can build a clinically driven skincare retail strategy grounded in evidence-based care rather than marketing trends.
Dr Glynis Ablon discusses how...
06/04/2026
The Dermatologist
draelos
Videos
Sunscreen Trends in Dermatology: SPF, Ingredient Safety, and Skin of Color
06/04/2026
Zoe Diana Draelos, MD; Riya Gandhi, MA
Dr Zoe Diana Draelos discusses key sunscreen trends shaping dermatology practice, including SPF selection, water resistance, broad-spectrum protection, and evolving concerns around ingredient safety and AI-driven product rating apps.
Dr Zoe Diana Draelos discusses key sunscreen trends shaping dermatology practice, including SPF selection, water resistance, broad-spectrum protection, and evolving concerns around ingredient safety and AI-driven product rating apps.
Dr Zoe Diana Draelos discusses...
06/04/2026
The Dermatologist

Partner Reviewed

NEA Approved Features
Closing Gaps in Eczema Research
06/08/2026
Coleen Stern, MA
New research will explore key aspects of eczema, from the science and genetics behind inflammation to advanced screening and patient-reported outcomes.
New research will explore key aspects of eczema, from the science and genetics behind inflammation to advanced screening and patient-reported outcomes.
New research will explore key...
06/08/2026
The Dermatologist
NRS Approved Features
Artificial Intelligence for Rosacea Diagnosis Shows Both Promise and Shortcomings
04/06/2026
Eden Robins
Recent studies point to the potential of using artificial intelligence models to diagnose dermatologic conditions while noting that the current state of these tools may lead to misdiagnosis, inaccurate information, and inaccessible language.
Recent studies point to the potential of using artificial intelligence models to diagnose dermatologic conditions while noting that the current state of these tools may lead to misdiagnosis, inaccurate information, and inaccessible language.
Recent studies point to the...
04/06/2026
The Dermatologist
NEA Approved Features
Supporting the Transition to Self-Managed Care in Adolescents and Young Adults With Atopic Dermatitis
03/09/2026
Allison Loiselle, PhD; Jessica Garlewicz
The National Eczema Association offers practical guidance on assessing transition readiness and empowering adolescents and young adults as they move toward independent atopic dermatitis care.
The National Eczema Association offers practical guidance on assessing transition readiness and empowering adolescents and young adults as they move toward independent atopic dermatitis care.
The National Eczema Association...
03/09/2026
The Dermatologist
NRS Approved Features
Do Fungi Play a Role in Rosacea?
01/30/2026
Andrew Huff
Imbalances in the mycobiome may contribute to the development of this chronic skin condition.
Imbalances in the mycobiome may contribute to the development of this chronic skin condition.
Imbalances in the mycobiome may...
01/30/2026
The Dermatologist
NPF Endorsed Features
Position Statement: Routine TB Testing for IL-17 and IL-23 Inhibitors
01/30/2026
Lisa Kuhns, PhD, MD
A new NPF Medical Board/International Psoriasis Council joint position statement concludes that routine latent tuberculosis infection testing is unnecessary for patients with psoriasis who are taking IL-17 or IL-23 inhibitors.
A new NPF Medical Board/International Psoriasis Council joint position statement concludes that routine latent tuberculosis infection testing is unnecessary for patients with psoriasis who are taking IL-17 or IL-23 inhibitors.
A new NPF Medical...
01/30/2026
The Dermatologist
NAAF-Reviewed Content
Managing Alopecia Areata With JAK Inhibitors: Timing, Response, and Long-Term Strategy
01/30/2026
Brett A. King, MD, PhD
As JAK inhibitors reshape the treatment landscape for alopecia areata, clinicians face new questions about when to initiate treatment, therapeutic expectations, and management over time.
As JAK inhibitors reshape the treatment landscape for alopecia areata, clinicians face new questions about when to initiate treatment, therapeutic expectations, and management over time.
As JAK inhibitors reshape the...
01/30/2026
The Dermatologist
NEA Approved Features
Patient Self-Monitoring and Shared Decision-Making in Atopic Dermatitis
12/09/2025
Jessica Garlewicz
As eczema care continues to progress toward different treat-to-target and other shared treatment goals with patients, self-monitoring can be integral to support this evolving care framework.
As eczema care continues to progress toward different treat-to-target and other shared treatment goals with patients, self-monitoring can be integral to support this evolving care framework.
As eczema care continues to...
12/09/2025
The Dermatologist
NAAF-Reviewed Content
Psychosocial Impact of Alopecia Areata in Pediatric Populations
10/06/2025
Riya Gandhi, MA
Integrating mental health assessment and support into our management of this disease in children and adolescents is imperative to ensure positive quality of life outcomes.
Integrating mental health assessment and support into our management of this disease in children and adolescents is imperative to ensure positive quality of life outcomes.
Integrating mental health...
10/06/2025
The Dermatologist
NPF Endorsed Features
Psoriatic Disease and the Domino Effect of Comorbidities
10/06/2025
Lisa Kuhns, PhD, MD
Research has consistently shown that people with psoriasis and psoriatic arthritis face higher rates of serious comorbidities
Research has consistently shown that people with psoriasis and psoriatic arthritis face higher rates of serious comorbidities
Research has consistently shown...
10/06/2025
The Dermatologist
NRS Approved Features
New Study Finds Skin Microbiome Differences Between Rosacea and Similar Conditions
10/06/2025
Andrew Huff
The community of microorganisms present on our skin may play an important role in the development of steroid-induced rosacea and perioral dermatitis.
The community of microorganisms present on our skin may play an important role in the development of steroid-induced rosacea and perioral dermatitis.
The community of microorganisms...
10/06/2025
The Dermatologist

News and FDA Alerts

sunscreen
News
FDA Approves Bemotrizinol: What Dermatologists Need to Know
06/11/2026
Jane Y. Yoo, MD; Riya Gandhi, MA
The Dermatologist spoke with Dr Jane Yoo about the FDA’s landmark approval of bemotrizinol. Dr Yoo discusses how this photostable, broad-spectrum UV filter may improve UVA protection, expand cosmetically elegant sunscreen options for diverse...
The Dermatologist spoke with Dr Jane Yoo about the FDA’s landmark approval of bemotrizinol. Dr Yoo discusses how this photostable, broad-spectrum UV filter may improve UVA protection, expand cosmetically elegant sunscreen options for diverse...
The Dermatologist spoke with Dr...
06/11/2026
The Dermatologist
FDA Alert
FDA Alerts
FDA Approves Every-8-Week Maintenance Dosing Option for Lebrikizumab in Atopic Dermatitis
06/10/2026
Jessica Garlewicz
The FDA approved an every-8-week maintenance dosing regimen for Ebglyss (lebrikizumab-lbkz), providing a new administration option for adults and adolescents aged 12 years and older weighing at least 40 kg with moderate-to-severe atopic...
The FDA approved an every-8-week maintenance dosing regimen for Ebglyss (lebrikizumab-lbkz), providing a new administration option for adults and adolescents aged 12 years and older weighing at least 40 kg with moderate-to-severe atopic...
The FDA approved an every-8-week...
06/10/2026
The Dermatologist
nail
News
Nail Abnormalities Common in Severe Atopic Dermatitis, Study Finds
06/09/2026
Jessica Garlewicz
Nail abnormalities may be highly prevalent among adults with severe atopic dermatitis (AD) and appear closely associated with disease severity.
Nail abnormalities may be highly prevalent among adults with severe atopic dermatitis (AD) and appear closely associated with disease severity.
Nail abnormalities may be highly...
06/09/2026
The Dermatologist
baby
News
Emergency Department Management of Pediatric Atopic Dermatitis Requires Accurate Triage and Structured Discharge Planning
06/09/2026
Jessica Garlewicz
Atopic dermatitis, the most common inflammatory skin disease of childhood, affects up to 20% of children in the United States and remains a frequent reason for emergency department visits.
Atopic dermatitis, the most common inflammatory skin disease of childhood, affects up to 20% of children in the United States and remains a frequent reason for emergency department visits.
Atopic dermatitis, the most...
06/09/2026
The Dermatologist
aging
News
Age-Specific Immune Signatures Identified Across the Atopic Dermatitis Lifespan
06/09/2026
Jessica Garlewicz
Using Cellular Indexing of Transcriptomes and Epitopes by sequencing, investigators simultaneously assessed transcriptomic and surface proteomic profiles across approximately 280,000 immune cells.
Using Cellular Indexing of Transcriptomes and Epitopes by sequencing, investigators simultaneously assessed transcriptomic and surface proteomic profiles across approximately 280,000 immune cells.
Using Cellular Indexing of...
06/09/2026
The Dermatologist
random
News
Psoriasis Not Genetically Linked to Renal Impairment, Mendelian Randomization Study Finds
06/04/2026
Jessica Garlewicz
A Mendelian randomization study found no evidence that genetic susceptibility to psoriasis causally contributes to renal impairment, challenging prior observational reports that have linked psoriasis to kidney dysfunction.
A Mendelian randomization study found no evidence that genetic susceptibility to psoriasis causally contributes to renal impairment, challenging prior observational reports that have linked psoriasis to kidney dysfunction.
A Mendelian randomization study...
06/04/2026
The Dermatologist
psoriasis
News
Biologic Therapy Not Linked to Overall Reduction in Psoriatic Arthritis Risk
06/04/2026
Jessica Garlewicz
Biologic therapy was not associated with a significantly reduced overall risk of incident psoriatic arthritis among patients with psoriasis, although subgroup findings suggested potential differences by data source and biologic class.
Biologic therapy was not associated with a significantly reduced overall risk of incident psoriatic arthritis among patients with psoriasis, although subgroup findings suggested potential differences by data source and biologic class.
Biologic therapy was not...
06/04/2026
The Dermatologist
stomach
News
Psoriasis May Be Associated With Greater Treatment Burden in Patients With Inflammatory Bowel Disease
06/04/2026
Jessica Garlewicz
Patients with inflammatory bowel disease (IBD) and preexisting psoriasis may require more intensive treatment and experience a more aggressive disease course than patients with IBD alone.
Patients with inflammatory bowel disease (IBD) and preexisting psoriasis may require more intensive treatment and experience a more aggressive disease course than patients with IBD alone.
Patients with inflammatory bowel...
06/04/2026
The Dermatologist
knees
News
Psoriasis May Be Linked to Accelerated Cellular Senescence Through Inflammaging Pathways
06/04/2026
Jessica Garlewicz
The review highlights the role of chronic immune activation in driving persistent inflammation.
The review highlights the role of chronic immune activation in driving persistent inflammation.
The review highlights the role...
06/04/2026
The Dermatologist
GPP
News
Spesolimab Shows Potential in Treating GPP With Palmoplantar Pustulosis
05/20/2026
Jessica Garlewicz
Spesolimab, an interleukin-36 receptor antagonist, may offer an effective treatment option for patients with generalized pustular psoriasis complicated by palmoplantar pustulosis.
Spesolimab, an interleukin-36 receptor antagonist, may offer an effective treatment option for patients with generalized pustular psoriasis complicated by palmoplantar pustulosis.
Spesolimab, an interleukin-36...
05/20/2026
The Dermatologist

Quizzes and Polls

Quiz
Type 2 Endotypes and Therapeutic Strategy in Prurigo Nodularis
06/25/2026
Riya Gandhi, MA
Assess advanced concepts in type 2 inflammatory endotypes, shared therapeutic pathways, and practical treatment approaches in prurigo nodularis.
Assess advanced concepts in type 2 inflammatory endotypes, shared therapeutic pathways, and practical treatment approaches in prurigo nodularis.
Assess advanced concepts in type...
06/25/2026
The Dermatologist
itch
Quiz
Fibrosis and Persistent Itch in Prurigo Nodularis
06/15/2026
Riya Gandhi, MA
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your clinical understanding...
06/15/2026
The Dermatologist
brain
Quiz
Neuroimmune Mechanisms and Cytokine Signaling in Prurigo Nodularis
06/05/2026
Riya Gandhi, MA
Explore advanced concepts in neuroimmune communication, cytokine-driven itch amplification, and fibrotic signaling pathways involved in prurigo nodularis.
Explore advanced concepts in neuroimmune communication, cytokine-driven itch amplification, and fibrotic signaling pathways involved in prurigo nodularis.
Explore advanced concepts in...
06/05/2026
The Dermatologist
Quiz
Predicting Disease Severity and Persistence in Pediatric Atopic Dermatitis
04/15/2026
Riya Gandhi, MA
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in...
04/15/2026
The Dermatologist
Quiz
Type 2 Inflammation and Early Systemic Therapy in Pediatric Atopic Dermatitis
04/05/2026
Riya Gandhi, MA
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical...
04/05/2026
The Dermatologist
Quiz
Disease Heterogeneity in PN
03/15/2026
Riya Gandhi, MA
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of...
03/15/2026
The Dermatologist
Quiz
Rethinking Severity and JAK Inhibitor Strategy in Alopecia Areata
03/12/2026
Riya Gandhi, MA
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine...
03/12/2026
The Dermatologist
Quiz
Cytokine Hierarchy and Sustained Pruritus in PN
03/10/2026
Riya Gandhi, MA
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and...
03/10/2026
The Dermatologist
Quiz
Type 2 Inflammation as a Pathogenic Driver in Prurigo Nodularis
03/05/2026
Riya Gandhi, MA
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how...
03/05/2026
The Dermatologist
psoriasis
Quiz
Distinguishing Feature of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing...
03/02/2026
The Dermatologist

Professional Development

Dr Adam Friedman
Podcasts
The Real Derm: Episode 5, Diving Deep Into the DermPath Pathway: A Candidate's Perspective
07/10/2025
Adam Friedman, MD
Climbing the mountain to get to dermatology residency is bone breaking enough, but what about the next apex, even more specialized training such as a Dermatopathology Fellowship?
Climbing the mountain to get to dermatology residency is bone breaking enough, but what about the next apex, even more specialized training such as a Dermatopathology Fellowship?
Climbing the mountain to get to...
07/10/2025
The Dermatologist
Dr. Adam Friedman and Jaya Manjunath
Podcasts
The Elderderm: Episode 4, Combatting Barriers to Care For Elder Patients
10/16/2024
Adam Friedman, MD
Collaboration and consideration are key to a successful medical intervention.
Collaboration and consideration are key to a successful medical intervention.
Collaboration and consideration...
10/16/2024
The Dermatologist
The ElderDerm: Episode 3, Shared- Decision Making
Podcasts
The ElderDerm: Episode 3, Shared-Decision Making
05/16/2024
Adam Friedman, MD; Jaya Manjunath
In our next segment of the ElderDerm Podcast, listen to co-hosts Dr Adam Friedman and Jaya Manjunath discuss what shared decision-making is, and why it is important in dermatology.
In our next segment of the ElderDerm Podcast, listen to co-hosts Dr Adam Friedman and Jaya Manjunath discuss what shared decision-making is, and why it is important in dermatology.
In our next segment of the...
05/16/2024
The Dermatologist
Aging and Geriatric Evaluation in Dermatology
Podcasts
The ElderDerm: Episode 2, Aging and Geriatric Evaluation in Dermatology
04/22/2024
Adam Friedman, MD; Jaya Manjunath
In this episode of the ElderDerm Podcast, co-hosts Dr Adam Friedman and Jaya Manjunath discuss the Aging and Geriatric Evaluation in Dermatology (AGED) workgroup.
In this episode of the ElderDerm Podcast, co-hosts Dr Adam Friedman and Jaya Manjunath discuss the Aging and Geriatric Evaluation in Dermatology (AGED) workgroup.
In this episode of the ElderDerm...
04/22/2024
The Dermatologist
ElderDerm
Podcasts
The ElderDerm: Episode 1, Geriatric Dermatology
01/29/2024
Jaya Manjunath; Adam Friedman, MD
Listen to the first ElderDerm Podcast, where co-hosts Dr Adam Friedman and Jaya Manjunath discuss what is geriatric dermatology, and why there is a need for this area in training.
Listen to the first ElderDerm Podcast, where co-hosts Dr Adam Friedman and Jaya Manjunath discuss what is geriatric dermatology, and why there is a need for this area in training.
Listen to the first ElderDerm...
01/29/2024
The Dermatologist

Conference Coverage

green
Videos
Hormonal Therapy in Acne: DHT, Spironolactone, and Clascoterone
06/04/2026
Lawrence J. Green, MD, FAAD; Riya Gandhi, MA
Dr Lawrence Green discusses how androgens and DHT contribute to acne pathogenesis through sebum production, inflammation, and abnormal keratinization.
Dr Lawrence Green discusses how androgens and DHT contribute to acne pathogenesis through sebum production, inflammation, and abnormal keratinization.
Dr Lawrence Green discusses how...
06/04/2026
The Dermatologist
Minokadeh
Videos
Injectables for the Male Face: Neuromodulator Dosing and Filler Techniques
06/04/2026
Ardalan Minokadeh, MD, PhD; Riya Gandhi, MA
Dr Ardalan Minokadeh discusses how injectable treatments should be tailored to male facial anatomy, including differences in muscle mass, brow shape, jaw structure, and midface contours.
Dr Ardalan Minokadeh discusses how injectable treatments should be tailored to male facial anatomy, including differences in muscle mass, brow shape, jaw structure, and midface contours.
Dr Ardalan Minokadeh discusses...
06/04/2026
The Dermatologist
Ablon
Videos
Dermatology Retail and Skincare Recommendations: Evidence-Based Strategies for Practices
06/04/2026
Glynis Ablon; Riya Gandhi, MA
Dr Glynis Ablon discusses how dermatology practices can build a clinically driven skincare retail strategy grounded in evidence-based care rather than marketing trends.
Dr Glynis Ablon discusses how dermatology practices can build a clinically driven skincare retail strategy grounded in evidence-based care rather than marketing trends.
Dr Glynis Ablon discusses how...
06/04/2026
The Dermatologist
draelos
Videos
Sunscreen Trends in Dermatology: SPF, Ingredient Safety, and Skin of Color
06/04/2026
Zoe Diana Draelos, MD; Riya Gandhi, MA
Dr Zoe Diana Draelos discusses key sunscreen trends shaping dermatology practice, including SPF selection, water resistance, broad-spectrum protection, and evolving concerns around ingredient safety and AI-driven product rating apps.
Dr Zoe Diana Draelos discusses key sunscreen trends shaping dermatology practice, including SPF selection, water resistance, broad-spectrum protection, and evolving concerns around ingredient safety and AI-driven product rating apps.
Dr Zoe Diana Draelos discusses...
06/04/2026
The Dermatologist
kelly
Videos
Optical Imaging in Dermatology: Real-Time Diagnosis and Noninvasive Skin Cancer Monitoring
06/04/2026
Kristen Kelly, MD; Riya Gandhi, MA
Dr Kristen Kelly discusses how bedside optical imaging technologies are transforming dermatologic diagnosis, treatment planning, and longitudinal monitoring for skin cancers and other conditions.
Dr Kristen Kelly discusses how bedside optical imaging technologies are transforming dermatologic diagnosis, treatment planning, and longitudinal monitoring for skin cancers and other conditions.
Dr Kristen Kelly discusses how...
06/04/2026
The Dermatologist
thor
Videos
BMI, Biological Aging, and Skin Longevity: Beyond Weight in Dermatology
06/04/2026
Dominik Thor, PhD, MSc; Riya Gandhi, MA
Dominik Thor discusses how obesity, metabolic health, and biological aging intersect to influence skin health and longevity.
Dominik Thor discusses how obesity, metabolic health, and biological aging intersect to influence skin health and longevity.
Dominik Thor discusses how...
06/04/2026
The Dermatologist
ablon
Videos
GLP-1 Dermatologic Side Effects: Facial Volume Loss, Hair Loss, and Skin Changes
06/04/2026
Glynis Ablon; Riya Gandhi, MA
Dr Glynis Ablon discusses the most common dermatologic effects associated with GLP-1 receptor agonists, including facial volume loss, skin laxity, telogen effluvium, hypersensitivity reactions, and delayed wound healing.
Dr Glynis Ablon discusses the most common dermatologic effects associated with GLP-1 receptor agonists, including facial volume loss, skin laxity, telogen effluvium, hypersensitivity reactions, and delayed wound healing.
Dr Glynis Ablon discusses the...
06/04/2026
The Dermatologist
green
Videos
Nutrition and Skin Aging: Antioxidants, Inflammation, and Healthy Skin Longevity
06/04/2026
Lawrence J. Green, MD, FAAD; Riya Gandhi, MA
Dr Lawrence Green discusses how nutrition influences skin aging through oxidative stress, inflammation, and advanced glycation end products.
Dr Lawrence Green discusses how nutrition influences skin aging through oxidative stress, inflammation, and advanced glycation end products.
Dr Lawrence Green discusses how...
06/04/2026
The Dermatologist
draelos
Videos
Hair Growth Supplements: Evidence-Based Ingredients and Patient Counseling
06/04/2026
Zoe Diana Draelos, MD; Riya Gandhi, MA
Dr. Zoe Diana Draelos discusses how dermatologists can evaluate hair growth supplements based on clinical evidence rather than marketing claims.
Dr. Zoe Diana Draelos discusses how dermatologists can evaluate hair growth supplements based on clinical evidence rather than marketing claims.
Dr. Zoe Diana Draelos discusses...
06/04/2026
The Dermatologist
kelly
Videos
Port Wine Capillary Malformations: Laser Treatment and Emerging Options
06/04/2026
Kristen Kelly, MD; Riya Gandhi, MA
Dr Kristen Kelly discusses current and emerging treatment strategies for port wine capillary malformations, including pulsed dye laser, long-pulsed 532 nm lasers, IPL, Alexandrite, and 1064 nm approaches.
Dr Kristen Kelly discusses current and emerging treatment strategies for port wine capillary malformations, including pulsed dye laser, long-pulsed 532 nm lasers, IPL, Alexandrite, and 1064 nm approaches.
Dr Kristen Kelly discusses...
06/04/2026
The Dermatologist

Popular Articles

vitiligo
News
Evaluating Efficacy of Ritlecitinib With or Without nbUVB in Treating Non-Segmental Vitiligo
06/28/2024
Riya Gandhi, MA
Ritlecitinib, a JAK3/TEC family kinase inhibitor, has shown promising results in the treatment of non-segmental vitiligo (NSV), according to a recent Phase 2b trial.
Ritlecitinib, a JAK3/TEC family kinase inhibitor, has shown promising results in the treatment of non-segmental vitiligo (NSV), according to a recent Phase 2b trial.
Ritlecitinib, a JAK3/TEC family...
06/28/2024
The Dermatologist
Conference Preview
“One for All:” DNA Annual Convention Preview
09/06/2024
Olanda Hathaway, MSN, FNP-BC, DCNP
The Dermatology Nurses’ Association hosts its 43rd yearly meeting in Orlando, FL, March 5–8, 2025, offering in-person educational and networking opportunities to promote patient care excellence.
The Dermatology Nurses’ Association hosts its 43rd yearly meeting in Orlando, FL, March 5–8, 2025, offering in-person educational and networking opportunities to promote patient care excellence.
The Dermatology Nurses’...
09/06/2024
The Dermatologist
acne
News
Topical Clindamycin: A Safe Choice for Acne Treatment Despite GI Concerns
10/31/2024
Riya Gandhi, MA
A recent review highlighted the safety of topical clindamycin, a popular antibiotic treatment for acne vulgaris.
A recent review highlighted the safety of topical clindamycin, a popular antibiotic treatment for acne vulgaris.
A recent review highlighted the...
10/31/2024
The Dermatologist
Clinical Insights
The Risk of Keratinocyte Cancer in Patients With Vitiligo
08/05/2024
Riya Gandhi, MA
A recent systematic review and meta-analysis offers insights into the relationship between vitiligo and nonmelanoma skin cancer, which can be used to enhance patient education.
A recent systematic review and meta-analysis offers insights into the relationship between vitiligo and nonmelanoma skin cancer, which can be used to enhance patient education.
A recent systematic review and...
08/05/2024
The Dermatologist
atopic dermatitis
FDA Alerts
Lebrikizumab FDA Approved for Moderate to Severe Atopic Dermatitis in Adults and Children
09/16/2024
Jessica Garlewicz
The US Food and Drug Administration has approved Eli Lilly’s EBGLYSS (lebrikizumab-lbkz), an IL-13 inhibitor, for the treatment of moderate to severe atopic dermatitis in adults and children.
The US Food and Drug Administration has approved Eli Lilly’s EBGLYSS (lebrikizumab-lbkz), an IL-13 inhibitor, for the treatment of moderate to severe atopic dermatitis in adults and children.
The US Food and Drug...
09/16/2024
The Dermatologist
June 2026 issue

Current Issue

June 2026
Volume 34
Issue 4
Current Issue
Issue Archive

Latest Quizzes and Trivia

Quiz
Type 2 Endotypes and Therapeutic Strategy in Prurigo Nodularis
06/25/2026
Riya Gandhi, MA
Assess advanced concepts in type 2 inflammatory endotypes, shared therapeutic pathways, and practical treatment approaches in prurigo nodularis.
Assess advanced concepts in type 2 inflammatory endotypes, shared therapeutic pathways, and practical treatment approaches in prurigo nodularis.
Assess advanced concepts in type...
06/25/2026
The Dermatologist
itch
Quiz
Fibrosis and Persistent Itch in Prurigo Nodularis
06/15/2026
Riya Gandhi, MA
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your clinical understanding...
06/15/2026
The Dermatologist
brain
Quiz
Neuroimmune Mechanisms and Cytokine Signaling in Prurigo Nodularis
06/05/2026
Riya Gandhi, MA
Explore advanced concepts in neuroimmune communication, cytokine-driven itch amplification, and fibrotic signaling pathways involved in prurigo nodularis.
Explore advanced concepts in neuroimmune communication, cytokine-driven itch amplification, and fibrotic signaling pathways involved in prurigo nodularis.
Explore advanced concepts in...
06/05/2026
The Dermatologist
Quiz
Predicting Disease Severity and Persistence in Pediatric Atopic Dermatitis
04/15/2026
Riya Gandhi, MA
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in...
04/15/2026
The Dermatologist
Quiz
Type 2 Inflammation and Early Systemic Therapy in Pediatric Atopic Dermatitis
04/05/2026
Riya Gandhi, MA
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical...
04/05/2026
The Dermatologist
Quiz
Disease Heterogeneity in PN
03/15/2026
Riya Gandhi, MA
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of...
03/15/2026
The Dermatologist
Quiz
Rethinking Severity and JAK Inhibitor Strategy in Alopecia Areata
03/12/2026
Riya Gandhi, MA
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine...
03/12/2026
The Dermatologist
Quiz
Cytokine Hierarchy and Sustained Pruritus in PN
03/10/2026
Riya Gandhi, MA
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and...
03/10/2026
The Dermatologist
Quiz
Type 2 Inflammation as a Pathogenic Driver in Prurigo Nodularis
03/05/2026
Riya Gandhi, MA
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how...
03/05/2026
The Dermatologist
psoriasis
Quiz
Distinguishing Feature of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing...
03/02/2026
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use